NN Investment Partners Holdings N.V. - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 872 filers reported holding BAXTER INTL INC in Q2 2016. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
NN Investment Partners Holdings N.V. ownership history of BAXTER INTL INC
ValueSharesWeighting
Q1 2022$7,773,000
-15.2%
100,252
-6.1%
0.04%
-8.7%
Q4 2021$9,165,000
+8.6%
106,756
+1.7%
0.05%
-2.1%
Q3 2021$8,443,000
-7.6%
104,961
-7.5%
0.05%
-4.1%
Q2 2021$9,133,000
-4.7%
113,455
-0.1%
0.05%
-12.5%
Q1 2021$9,579,000
-71.3%
113,574
-72.7%
0.06%
-72.4%
Q4 2020$33,368,000
-13.4%
415,873
-13.2%
0.20%
-18.5%
Q3 2020$38,538,000
+39.1%
479,178
+48.9%
0.25%
+33.9%
Q2 2020$27,712,000
+6.1%
321,849
+0.1%
0.19%
-12.7%
Q1 2020$26,112,000
+19.6%
321,604
+23.1%
0.21%
+43.9%
Q4 2019$21,840,000
+9.5%
261,192
+14.5%
0.15%
-5.1%
Q3 2019$19,947,000
+5.8%
228,034
-1.0%
0.16%
+4.7%
Q2 2019$18,857,000
+0.9%
230,241
+0.2%
0.15%
+2.1%
Q1 2019$18,683,000
+7.8%
229,763
-12.8%
0.15%
-0.7%
Q4 2018$17,337,000
-21.8%
263,403
-8.4%
0.15%
-8.1%
Q3 2018$22,166,000
+14.2%
287,551
+9.4%
0.16%
+12.7%
Q2 2018$19,414,000
-33.1%
262,921
-41.0%
0.14%
-32.1%
Q1 2018$29,000,000
-30.9%
445,891
-31.3%
0.21%
-29.4%
Q4 2017$41,960,000
-26.9%
649,133
-29.0%
0.30%
-18.9%
Q3 2017$57,396,000
+96.5%
914,672
+89.5%
0.36%
+35.2%
Q2 2017$29,216,000
+19.5%
482,579
+2.3%
0.27%
+16.4%
Q1 2017$24,458,000
+192.6%
471,627
+150.2%
0.23%
+193.7%
Q4 2016$8,359,000
-72.9%
188,518
-70.9%
0.08%
-72.8%
Q3 2016$30,868,000
-18.7%
648,491
-22.8%
0.29%
-19.2%
Q2 2016$37,984,000
-19.6%
839,991
-27.0%
0.36%
-20.9%
Q1 2016$47,267,0001,150,6180.45%
Other shareholders
BAXTER INTL INC shareholders Q2 2016
NameSharesValueWeighting ↓
Third Point 41,000,000$2,482,140,00022.00%
THUNDERBIRD PARTNERS LLP 1,711,643$103,623,00012.17%
SECTOR GAMMA AS 1,070,333$64,798,0009.42%
Veritas Asset Management LLP 10,179,102$616,243,0004.81%
13D Management LLC 194,807$11,794,0004.18%
Progressive Investment Management Corp 78,316$4,741,0003.69%
Aristotle Capital Management, LLC 6,846,307$414,476,0003.46%
ARGENT CAPITAL MANAGEMENT LLC 1,394,075$84,397,0003.37%
Lipe & Dalton 80,073$4,848,0003.14%
PURA VIDA INVESTMENTS, LLC 125,000$7,568,0003.00%
View complete list of BAXTER INTL INC shareholders